Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vertex Pharmaceuticals Incorporated (VRTX) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance

Vertex Pharmaceuticals IncorporatedTrade
State Street Technology Select Sector SPDR ETFTrade

Price performance (Past 24H)

Key statistics

Vertex Pharmaceuticals Incorporated vs State Street Technology Select Sector SPDR ETF — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.47 (market cap $121.95B), while State Street Technology Select Sector SPDR ETF trades at $180.7. Which is the better fit depends on your goals.

VRTXXLK
Market Cap
$121.95B
Sector
HealthSector/Thematic
52-Week High
$529.59$198.21
52-Week Low
$366.54$127.49
Enterprise Value
$116.69B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX

About State Street Technology Select Sector SPDR ETF

XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.

Read more on XLK